Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279954 · ClinicalTrials.gov registry record · Phase 2
Abatacept in the Treatment of Uveitis
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01279954 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants.
The verdict
NCT01279954, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.
Interventions
- DRUG Abatacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279954
The ClinicalTrials.gov registry entry for NCT01279954 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Abatacept is the first listed.
NCT01279954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01279954 about?
NCT01279954 is a clinical study titled "Abatacept in the Treatment of Uveitis". The purpose of this study is to assess the safety and efficacy of abatacept in the treatment of uveitis.
What is the current status of trial NCT01279954?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2012-01. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01279954?
The interventions under investigation include: Abatacept (DRUG).
Who is sponsoring clinical trial NCT01279954?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.